FDA Grants Breakthrough Designation to Synapse Biomedical's TransAeris(R) System

OBERLIN, Ohio, July 21, 2021 -- (Healthcare Sales & Marketing Network) -- Synapse Biomedical, Inc®. (www.synapsebiomedical.com) announced today that the FDA has granted Breakthrough Therapy Device designation to TransAeris®, a temporary percutaneo... Devices, FDA Synapse Biomedical, TransAeris, diaphragm stimulator, mechanical ventilator
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news